Cadrenal Therapeutics (CVKD)
Nasdaq • CVKD • US1276362076
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 8.8% of free float sold short, 1.4 days to cover, cost to borrow 3.64%. Sign up for live short interest data.
Market Cap
5.07m USD | # 12026 in US
Volume
476.3k shares | 580.95k USD
Shares Outstanding
3.57m
Free Float Shares
90.27% | 3.22m
